Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117265) titled 'A Study to Assess Efficacy, Safety, and Tolerability of Elecoglipron and Dapagliflozin in Adults with Type 2 Diabetes Mellitus' on Sept. 9.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Centralized Blinding and masking:Participant and Investigator Blinded
Primary Sponsor: AstraZeneca AB
Condition:
Health Condition 1: E11- Type 2 diabetes mellitus
Intervention:
Intervention1: Elecoglipron: Formulation: Tablet
Dose strength: Dose 1
Route: Oral...